11/21
02:33 am
opk
The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade [Yahoo! Finance]
Low
Report
The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade [Yahoo! Finance]
11/20
08:07 am
opk
OPKO Health (NASDAQ:OPK) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating on the stock.
Medium
Report
OPKO Health (NASDAQ:OPK) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating on the stock.
11/19
04:05 pm
opk
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/15
11:51 pm
opk
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat [Yahoo! Finance]
Low
Report
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat [Yahoo! Finance]
11/6
08:18 am
opk
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting [Yahoo! Finance]
Low
Report
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting [Yahoo! Finance]
10/30
11:45 pm
opk
Opko Health Inc.'s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals [Yahoo! Finance]
Low
Report
Opko Health Inc.'s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals [Yahoo! Finance]
10/30
07:01 pm
opk
OPKO Health (NASDAQ:OPK) was given a new $1.60 price target on by analysts at Jefferies Financial Group Inc..
Medium
Report
OPKO Health (NASDAQ:OPK) was given a new $1.60 price target on by analysts at Jefferies Financial Group Inc..
10/30
08:09 am
opk
OPKO Health (NASDAQ:OPK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
Low
Report
OPKO Health (NASDAQ:OPK) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
10/29
04:05 pm
opk
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
Low
Report
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
10/29
08:00 am
opk
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
Medium
Report
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
10/28
08:00 am
opk
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
Low
Report
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
10/27
01:00 pm
opk
Greenberg Traurig Selected as Winner at 2025 Beacon Awards in Professional Services Category
Low
Report
Greenberg Traurig Selected as Winner at 2025 Beacon Awards in Professional Services Category
10/22
04:05 pm
opk
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
Low
Report
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
10/13
08:20 am
opk
GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program [Yahoo! Finance]
Neutral
Report
GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program [Yahoo! Finance]
10/9
08:19 am
opk
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program [Yahoo! Finance]
Low
Report
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program [Yahoo! Finance]
10/8
08:19 am
opk
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting [Yahoo! Finance]
Neutral
Report
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting [Yahoo! Finance]
10/7
08:11 pm
opk
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 [Yahoo! Finance]
Low
Report
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 [Yahoo! Finance]
10/1
04:33 pm
opk
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award [Yahoo! Finance]
Low
Report
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award [Yahoo! Finance]
9/30
08:47 am
opk
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth [Yahoo! Finance]
Medium
Report
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth [Yahoo! Finance]
9/25
08:17 am
opk
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference [Yahoo! Finance]
Low
Report
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference [Yahoo! Finance]
9/15
09:02 am
opk
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses [Yahoo! Finance]
Low
Report
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses [Yahoo! Finance]